-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Arbutus Biopharma Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q2 2024.
- Arbutus Biopharma Corp Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.18M, a 7.29% increase year-over-year.
- Arbutus Biopharma Corp Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.4M, a 10.9% increase year-over-year.
- Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2023 was $9.3M, a 29.5% increase from 2022.
- Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2022 was $7.18M, a 11.8% increase from 2021.
- Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2021 was $6.42M, a 4.27% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)